Colorectal Cancer
Conditions
Keywords
Screening, Participation
Brief summary
The effect of mailing FIT with the invitation on participation and colonoscopy rates will be evaluated in a randomized controlled trial conducted in the Centre-Val de Loire (CVL) region, involving 64,000 people from the population eligible for colorectal cancer population-based organised screening program (CRC-PBOSP). In the "C" control group, invitations, test delivery and reminders will be carried out in accordance with the CRC-PBOSP rules at the time of the study. Intervention group "B" will evaluate two experimental modes of invitation with direct home mailing of the test: * Method "B1": invitation with test sent to home without prior information letter * Method "B2": information letter followed by invitation with test sent home, designed to optimize participation by first-time subjects (aged 50-51) invited to the CRC-PBOSP for the first time. Ancillary studies will focus 1/ on acceptability of this intervention (qualitative study on a few general practitioners, gastroenterologists and invitees), 2/ on social and geographical inequalities of participation on a subsample of individuals included in EXPEDIT study using ecological indices (EDI, SCALE).
Interventions
The invitation to CRC-PBOSP will only contain informations on how to get the screening test.
The invitation to CRC-PBOSP will contain the CRC screening test.
An information letter will be sent to future invitees a few weeks before the invitation, to announce the mailing of the CRC screening kit.
Sponsors
Study design
Intervention model description
The number of study arms will differ according to age-group: * In 50 or 51 yrs age-group, individuals (n=5760 ) will be randomised in 3 groups: C, B1 and B2 (allocation ratio 2:1:1) * In the age-group older than 51 yrs, individuals (n=58240) will be randomised in 2 groups: C, and B1 (allocation 1:1) In the main analysis including both age-groups, B1 and B2 arms would be pooled.
Eligibility
Inclusion criteria
* 50 to 74 years old * Resident of Centre Val de Loire French area * Eligible for CRC screening invitation within the biennal CRC-PBOSP during the inclusion period * Affiliated to the health insurance scheme
Exclusion criteria
* CRC screening
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Performance of colonoscopy in FIT positive patients | 6 months after the positive FIT | Rate of Colonoscopy within 6 months after positive FIT among invitees with a positive FIT |
| Participation to CRC screening program | 16 months after the invitation | Rate of FIT sent to laboratory for analysis within 16 of months of invitation among invitees. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Participation to CRC screening program at 24 months | 24 months after invitation | Rate of FIT sent to laboratory for analysis within 24 of months of invitation among invitees. |
| Time to screening participation | 24 months after invitation | Time to screening participation within 24 months of invitation among invitees |
| Colonoscopy in FIT positive patients, 12 months after the positive test | 12 months after the positive test | Rate of Colonoscopy within 12 months after positive FIT among invitees with a positive FIT |
| Time to colonoscopy (in FIT positive patients) | 12 months after the positive test | Time from FIT to colonoscopy within 12 months of positive FIT among invitees with a positive FIT |
| Cost-effectiveness analysis | 24 months | Costs of CSC-PBOSP from invitation to colonoscopy when necessary |
| Colonoscopy findings | 12 months after the positive test | Rate of colorectal cancer or advanced neaplasia in invitees with a positive FIT |
| Participation to CRC screening program in first invitees (50-51 yrs-old) | 16 months after invitation | Rate of FIT sent to laboratory for analysis within 16 of months of invitation among first invitees (50-51 yrs-old) |
Countries
France